DTH skin tests with synthetic peptides derived from the VDJ sequence of the tumor-specific Ig heavy chain: CDR3-derived peptide (solid arrow) or an equivalent amount of FR3-derived peptide (open arrow) were injected intradermally side-by-side into the forearm.